Remedium Lifecare Ltd vs Unjha Formulations Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Remedium Lifecare Ltd is ₹ 0.39 as of 13 Apr 15:30 . The P/E Ratio of Remedium Lifecare Ltd is 36.4 as of March 2025 .The P/E Ratio of Unjha Formulations Ltd is 0 as of March 2025 . The Market Cap of Remedium Lifecare Ltd is ₹ 73.38 crore as of March 2025 .The Market Cap of Unjha Formulations Ltd is ₹ 0 crore as of March 2025 . The Revenue of Remedium Lifecare Ltd is ₹ 264.98 crore as of Mar '25 .The Revenue of Unjha Formulations Ltd is ₹ 0 crore as of Mar '25 . The EBITDA of Remedium Lifecare Ltd is ₹ 0.2 crore as of Mar '25 .The EBITDA of Unjha Formulations Ltd is ₹ 0 crore as of Mar '25 . The Net Profit of Remedium Lifecare Ltd is ₹ -2.05 crore as of Mar '25 .The Net Profit of Unjha Formulations Ltd is ₹ 0 crore as of Mar '25 . The Dividend Payout of Remedium Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Unjha Formulations Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Remedium Lifecare Ltd

Remedium Lifecare Limited (Formerly known as 'Roxy Exports Limited) was incorporated in February 19, 1988.
Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from 'Roxy Exports Limited' to 'Remedium Lifecare Limited' vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies. The Company being a pharmaceutical company is aligned across two business verticals viz. products and services.
Products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. Apart from this, the Company is engaged in the business of trading in Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API's) and other pharma products used viz.

About Unjha Formulations Ltd

Unjha Formulations Ltd was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat.
It was promoted by Shambhubhai A Patel.
The Company is a pioneer in Isabgol (Psyllium) Formulation.
The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc.
It is one of the largest manufacturers of isabgul products in India.

FAQs for the comparison of Remedium Lifecare Ltd and Unjha Formulations Ltd

Which company has a larger market capitalization, Remedium Lifecare Ltd or Unjha Formulations Ltd?

Market cap of Remedium Lifecare Ltd is 40 Cr while Market cap of Unjha Formulations Ltd is 9 Cr

What are the key factors driving the stock performance of Remedium Lifecare Ltd and Unjha Formulations Ltd?

The stock performance of Remedium Lifecare Ltd and Unjha Formulations Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Remedium Lifecare Ltd and Unjha Formulations Ltd?

As of May 4, 2026, the Remedium Lifecare Ltd stock price is INR ₹0.46. On the other hand, Unjha Formulations Ltd stock price is INR ₹22.0.

How do dividend payouts of Remedium Lifecare Ltd and Unjha Formulations Ltd compare?

To compare the dividend payouts of Remedium Lifecare Ltd and Unjha Formulations Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.